Etodolac NDC 42799-111

NDC codes

FDA NDC Directory

Product NDC (as listed)42799-111Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42799-0111Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42799-111-01	42799011101	100 TABLET, FILM COATED in 1 BOTTLE (42799-111-01)Marketed from Dec 7, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Etodolac
Generic name (nonproprietary): etodolac
Active ingredients: Etodolac — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Edenbridge Pharmaceuticals LLC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209888
Marketing start: Dec 7, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 42799-111_462de1d4-dc95-527d-e063-6394a90ad55aSPL ID 462de1d4-dc95-527d-e063-6394a90ad55aSPL set ID bf1afcd5-e1da-4874-981f-f252cb0b32c2RxCUI 197686, 199390UNII 2M36281008UPC 0342799111018, 0342799112015
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442799011101 followed by a unit qualifier and the quantity

Package 42799-0111-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 17, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS & USAGE Carefully consider the potential benefits and risks of Etodolac Tablets and other treatment options before deciding to use Etodolac Tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac Tablets are indicated: For acute and long-term use in the management of signs and symptoms of the following: Osteoarthritis Rheumatoid arthritis For the management of acute pain

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209888

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209888
Product	Strength	Form · route	Labeler	Product NDC
Etodolac	Etodolac 500 mg/1	Tablet, Film coatedOral	Edenbridge Pharmaceuticals LLC.	42799-112
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-910
Etodolac	Etodolac 500 mg/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-911